Search
Search
About
Log in
Join
Experiences with
Castration
Posts
Communities
1,127 public posts
Filter results
Long term AR signaling‐targeted therapy with taxane sometimes associated with visceral metastasis in castration‐resistant prostate cancer
The present study was conducted to present androgen receptor signaling‐targeted therapy and taxane chemotherapy induce visceral metastasis in
castration
‐resistant prostate cancer.
The present study was conducted to present androgen receptor signaling‐targeted therapy and taxane chemotherapy induce visceral metastasis in
castration
‐resistant prostate cancer.
George71
in
Advanced Prostate Cancer
4 years ago
Greater Subcutaneous Fat Improves mCRPC Treatment Response
https://www.cancertherapyadvisor.com/home/cancer-topics/prostate-cancer/adipose-tissue-metastatic-
castration
-resistant-pca-tx-response/ I thought it was the other way around.
https://www.cancertherapyadvisor.com/home/cancer-topics/prostate-cancer/adipose-tissue-metastatic-
castration
-resistant-pca-tx-response/ I thought it was the other way around.
George71
in
Advanced Prostate Cancer
4 years ago
Not a candidate for the CAR-T trial. Should I pursue cabozantinib here in the USA or look abroad for LU-177?
Of course you need to have the PSMA receptor for this to be effective but I hear some really good regression is a number of men who have
castration
resistance and who have failed docetaxel. Any thoughts brothers?
Of course you need to have the PSMA receptor for this to be effective but I hear some really good regression is a number of men who have
castration
resistance and who have failed docetaxel. Any thoughts brothers?
Cleodman
in
Advanced Prostate Cancer
4 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
What is Changing in Advanced Prostate Cancer?
Isn't almost all metastatic PCa eventually
castration
resistant????
Isn't almost all metastatic PCa eventually
castration
resistant????
maley2711
in
Advanced Prostate Cancer
4 years ago
BAT
The bipolar androgen therapy is an under-investigation treatment that consists in periodical oscillation between
castration
levels and supraphysiological levels of testosterone in order to prevent the adaptation of prostate cancer cells to a low-androgen environment.
The bipolar androgen therapy is an under-investigation treatment that consists in periodical oscillation between
castration
levels and supraphysiological levels of testosterone in order to prevent the adaptation of prostate cancer cells to a low-androgen environment.
podsart
in
Advanced Prostate Cancer
4 years ago
Is ADT necessary when you take Zytiga?
"ADT, which causes
castration
, or the removal of androgens such as testosterone from the body, comes with many significant adverse side effects.
"ADT, which causes
castration
, or the removal of androgens such as testosterone from the body, comes with many significant adverse side effects.
pjoshea13
in
Advanced Prostate Cancer
4 years ago
Tolerability and treatment response to darolutamide in patients with nmCRPC in the phase III ARAMIS trial
Effectiveness related to the PSA decline from baseline. https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/tolerability-and-treatment-response-to-darolutamide-daro-in-patients-with-non-metastatic-
castration
-resistant-prostate-cancer-nmcrpc-in-the-pha
Effectiveness related to the PSA decline from baseline. https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/tolerability-and-treatment-response-to-darolutamide-daro-in-patients-with-non-metastatic-
castration
-resistant-prostate-cancer-nmcrpc-in-the-pha
tango65
in
Advanced Prostate Cancer
4 years ago
$150-200 Research Study for you
US residents only Confirmed mCRPC diagnosis (metastatic
castration
-resistant) Aim for mix of home setting (i.e. rural, urban, suburban) Aim for range of time since diagnosis Mix of patients with different number of lines of treatment received Mix of treatments Aim for mix of ethnicities Ryan Tomlinson
US residents only Confirmed mCRPC diagnosis (metastatic
castration
-resistant) Aim for mix of home setting (i.e. rural, urban, suburban) Aim for range of time since diagnosis Mix of patients with different number of lines of treatment received Mix of treatments Aim for mix of ethnicities Ryan Tomlinson
Darryl
Partner
in
Advanced Prostate Cancer
4 years ago
BAT: transformer trial
https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.5517 https://www.urotoday.com/conference-highlights/asco-2020/asco-2020-prostate-cancer/121890-asco-2020-transformer-bipolar-androgen-therapy-vs-enzalutamide-for-
castration
-resistant-metastatic-prostate-cancer.html https://www.urotoday.com/video-lectures
https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.5517 https://www.urotoday.com/conference-highlights/asco-2020/asco-2020-prostate-cancer/121890-asco-2020-transformer-bipolar-androgen-therapy-vs-enzalutamide-for-
castration
-resistant-metastatic-prostate-cancer.html https://www.urotoday.com/video-lectures
kaptank
in
Advanced Prostate Cancer
4 years ago
It's been a full week since my castration...and feeling GREAT.
My surgical orchidectomy was last Monday afternoon. In my attempt to keep everyone interested "posted" on my journey.... I have more energy than I have had in months(since before Radiation in Feb/Mar)....it might be because the weather has finally cooled down to the 70's and low 80's here in Ft. Lauderdale
My surgical orchidectomy was last Monday afternoon. In my attempt to keep everyone interested "posted" on my journey.... I have more energy than I have had in months(since before Radiation in Feb/Mar)....it might be because the weather has finally cooled down to the 70's and low 80's here in Ft. Lauderdale
greatjohn
in
Advanced Prostate Cancer
4 years ago
Title :Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
With all the interest in my last post I thought some might be interested in this: https://www.cureitt.com/trialdetails?nctid=NCT03123978 Maybe someone out there could explain the difference between niclosamide and Fenbendazole, they are both used for deworming dogs.
With all the interest in my last post I thought some might be interested in this: https://www.cureitt.com/trialdetails?nctid=NCT03123978 Maybe someone out there could explain the difference between niclosamide and Fenbendazole, they are both used for deworming dogs.
Magnus1964
in
Advanced Prostate Cancer
4 years ago
Castrate resistant with Mets
What is the life expectancy with stage 4
castration
resistant and Mets to three areas of the bones? On an average. He just started taking Zytiga!!
What is the life expectancy with stage 4
castration
resistant and Mets to three areas of the bones? On an average. He just started taking Zytiga!!
Fight11
in
Advanced Prostate Cancer
4 years ago
Recurrence after Therapy for Oligometastatic Castration Sensitive PCa
"Metastasis directed therapy (MDT) is increasingly used in
castration
-sensitive oligometastatic prostate cancer (OPCa) because it prolongs progression free survival (PFS) and androgen deprivation free survival."
"Metastasis directed therapy (MDT) is increasingly used in
castration
-sensitive oligometastatic prostate cancer (OPCa) because it prolongs progression free survival (PFS) and androgen deprivation free survival."
pjoshea13
in
Advanced Prostate Cancer
4 years ago
Princess Grace Hospital in Monaco
I chose RT plus chemical
castration
by 2 injections over six months of Enantone , Takeda Japanese Lab . My RT consisted of 38 sessions of 2Gy on Prostate , prealably contoured by three gold grains and my SV received 54 Gy . I asked why the SV also ?
I chose RT plus chemical
castration
by 2 injections over six months of Enantone , Takeda Japanese Lab . My RT consisted of 38 sessions of 2Gy on Prostate , prealably contoured by three gold grains and my SV received 54 Gy . I asked why the SV also ?
thierry
in
Prostate Cancer Network
4 years ago
New Car-T therapy announces initial results, how exercise helps in the fight against cancer, FDA approves EZRA AI for faster PC diagnosis
https://www.globenewswire.com/news-release/2020/10/26/2114227/0/en/Mustang-Bio-Announces-Initial-Phase-1-Data-on-MB-105-for-Patients-with-PSCA-positive-
Castration
-Resistant-Prostate-Cancer.html The clinical trial is STILL RECRUITING--out of City of Hope....some info: https://clinicaltrials.gov/ct2/show
https://www.globenewswire.com/news-release/2020/10/26/2114227/0/en/Mustang-Bio-Announces-Initial-Phase-1-Data-on-MB-105-for-Patients-with-PSCA-positive-
Castration
-Resistant-Prostate-Cancer.html The clinical trial is STILL RECRUITING--out of City of Hope....some info: https://clinicaltrials.gov/ct2/show
NPfisherman
in
Fight Prostate Cancer
4 years ago
Sipuleucel-T boosts survival versus abiraterone or enzalutamide alone in real-world mCRPC analysis
Real-world data showed that use of the immunotherapy sipuleucel-T (Provenge) during any line of treatment in men with metastatic
castration
-resistant prostate cancer (mCRPC) improved overall survival (OS) versus treatment regimens that included abiraterone acetate (Zytiga) or enzalutamide (Xtandi), but
Real-world data showed that use of the immunotherapy sipuleucel-T (Provenge) during any line of treatment in men with metastatic
castration
-resistant prostate cancer (mCRPC) improved overall survival (OS) versus treatment regimens that included abiraterone acetate (Zytiga) or enzalutamide (Xtandi), but
George71
in
Advanced Prostate Cancer
4 years ago
Oligorecurrent PCa
Predictors of RAR, SST, and
castration
-resistant PCa (CRPCa) were assessed with Cox regression analyses. Results: Overall, 74 (22.6%), 63 (19.2%), and 191 (58.2%) patients were treated with ADT, EBRT, and sLND for lymph node-only recurrence.
Predictors of RAR, SST, and
castration
-resistant PCa (CRPCa) were assessed with Cox regression analyses. Results: Overall, 74 (22.6%), 63 (19.2%), and 191 (58.2%) patients were treated with ADT, EBRT, and sLND for lymph node-only recurrence.
pjoshea13
in
Advanced Prostate Cancer
4 years ago
Update: A choice between 2 clinical trials as of yesterday afternoon. 1. AMG 509 and 2. Cocktail of 4 immunotherapy drugs.
This may be true for many types of cancer, including
castration
-resistant prostate cancer (CRPC). In this study, participants will receive treatment combinations of either 2, 3, or 4 different immunotherapy drugs (BN-brachyury, M7824, ALT-803 and Epacadostat).
This may be true for many types of cancer, including
castration
-resistant prostate cancer (CRPC). In this study, participants will receive treatment combinations of either 2, 3, or 4 different immunotherapy drugs (BN-brachyury, M7824, ALT-803 and Epacadostat).
Philly13
in
Advanced Prostate Cancer
4 years ago
Follow up: Auximen Scan showed significant new cancerous growth and there is a whirlwind of information to absorb and choices to be made.
Both Doctors say results have not supported this as an effective treatment for metastatic
castration
-resistant disease. 2. Chemotherapy-likely Docetaxel. 3. Radium 223 to treat the disease in my bones appears to be the only problem areas.
Both Doctors say results have not supported this as an effective treatment for metastatic
castration
-resistant disease. 2. Chemotherapy-likely Docetaxel. 3. Radium 223 to treat the disease in my bones appears to be the only problem areas.
Philly13
in
Advanced Prostate Cancer
4 years ago
Treatment of Nonmetastatic Castration-Resistant Prostate Cancer With Darolutamide
– Neil Majithia, MD BACKGROUND Darolutamide is a structurally distinct androgen-receptor inhibitor that is approved for the treatment of nonmetastatic,
castration
-resistant prostate cancer.
– Neil Majithia, MD BACKGROUND Darolutamide is a structurally distinct androgen-receptor inhibitor that is approved for the treatment of nonmetastatic,
castration
-resistant prostate cancer.
Balsam01
in
Advanced Prostate Cancer
4 years ago
1
...
26
27
28
...
57
Next page
10
20
30
40
50
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
1004 results
Fight Prostate Cancer
67 results
Prostate Cancer Network
25 results
View top 10 communities
Sort by
Most Relevant
Newest